Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
0.9061
-0.0364 (-3.86%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Apyx Medical Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Apyx Medical.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Apyx Medical stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 17, 2024 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 16, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +451.82% | Nov 10, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $4 → $4.5 | Buy | Maintains | $4 → $4.5 | +396.63% | Aug 11, 2023 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $8 | Buy | Initiates | $8 | +782.90% | Jul 14, 2023 |
Financial Forecast
Revenue This Year
48.99M
from 48.10M
Increased by 1.85%
Revenue Next Year
52.77M
from 48.99M
Increased by 7.72%
EPS This Year
-0.42
from -0.66
EPS Next Year
-0.41
from -0.42
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 50.6M | 54.9M | 63.2M | ||
| Avg | 49.0M | 52.8M | 61.4M | ||
| Low | 46.9M | 50.0M | 59.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.2% | 12.1% | 19.7% | ||
| Avg | 1.8% | 7.7% | 16.3% | ||
| Low | -2.4% | 2.0% | 11.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.40 | -0.39 | -0.38 |
| Avg | -0.42 | -0.41 | -0.37 |
| Low | -0.45 | -0.43 | -0.35 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.